Factor VII conjugates
US10179905B2 · kind B2 · utility
0Cited by
7References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 2017 |
| Grant date | Jan 15, 2019 |
| Priority date | — |
| Expiry date | Mar 8, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/21021
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the conjugation of Factor VII polypeptides with heparosan polymers. The resultant conjugates may be used to deliver Factor VII, for example in the treatment or prevention of bleeding disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.